Infliximab in primary Sjögren's syndrome: One-year followup-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Infliximab in primary Sjögren's syndrome: One-year followup

Published:2002-12 Issue:12 Volume:46 Page:3301-3303
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Steinfeld Serge D.,Demols Paul,Appelboom Thierry

Funder

Fund for Medical Scientific Research (FRSM), Belgium

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference5 articles.

1. Infliximab in patients with primary Sjögren's syndrome: a pilot study;Steinfeld;Arthritis Rheum,2001

2. Preliminary criteria for the classification of Sjögren's syndrome: results of a prospective concerted action supported by the European Community;Vitali;Arthritis Rheum,1993

3. Sjögren's syndrome: proposed criteria for classification;Fox;Arthritis Rheum,1986

4. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial.;Maini;Lancet,1999

5. Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor α monoclonal antibody infliximab;Brandt;Arthritis Rheum,2000

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease;Rheumatology;2024-04-16

2. Biologics in Sjogren’s Syndrome;Handbook of Biologics for Rheumatological Disorders;2022

3. Investigative biological therapies for primary Sjögren’s syndrome;Archives of Medical Science;2020-07-15

4. Recomendaciones SER sobre la utilización de fármacos biológicos en el síndrome de Sjögren primario;Reumatología Clínica;2019-11

5. SER recommendations on the use of biological drugs in primary Sjögren's syndrome;Reumatología Clínica (English Edition);2019-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3